Open Access

Pomegranate vinegar attenuates adiposity in obese rats through coordinated control of AMPK signaling in the liver and adipose tissue

  • Elly Ok1,
  • Gyeong-Min Do1,
  • Yeni Lim1,
  • Ji-Eun Park1,
  • Yeo-Jin Park1 and
  • Oran Kwon1Email author
Contributed equally
Lipids in Health and Disease201312:163

https://doi.org/10.1186/1476-511X-12-163

Received: 10 September 2013

Accepted: 29 October 2013

Published: 2 November 2013

Abstract

Background

The effect of pomegranate vinegar (PV) on adiposity was investigated in high-fat diet (HF)-induced obese rats.

Methods

The rats were divided into 5 groups and treated with HF with PV or acetic acid (0, 6.5 or 13% w/w) for 16 weeks. Statistical analyses were performed by the Statistical Analysis Systems package, version 9.2.

Results

Compared to control, PV supplementation increased phosphorylation of AMP-activated protein kinase (AMPK), leading to changes in mRNA expressions: increases for hormone sensitive lipase and mitochondrial uncoupling protein 2 and decreases for sterol regulatory element binding protein-1c (SREBP-1c) and peroxisome proliferator-activated receptorγ (PPARγ) in adipose tissue; increases for PPARα and carnitinepalmitoyltransferase-1a (CPT-1a) and decrease for SREBP-1c in the liver. Concomitantly, PV reduced increases of body weight (p = 0.048), fat mass (p = 0.033), hepatic triglycerides (p = 0.005), and plasma triglycerides (p = 0.001).

Conclusions

These results suggest that PV attenuates adiposity through the coordinated control of AMPK, which leads to promotion of lipolysis in adipose tissue and stimulation of fatty acid oxidation in the liver.

Keywords

High-fat diet-induced obesity Pomegranate vinegar AMP-activated protein kinase Hormone sensitive lipase Fatty acid oxidation

Background

Obesity is a chronic metabolic disorder that is characterized by excessive body fat and dysregulation of lipid metabolism. Hyperlipidemia in obesity is strongly associated with chronic diseases such as type 2 diabetes, cardiovascular disease, certain forms of cancer, and respiratory complications [1]. Currently two categories of medications are available to treat obesity: appetite suppressants and inhibitors of specific nutrient absorption. However, they often have undesirable side-effects. Therefore much attention has been focused on natural products, which may increase fat oxidation, decrease adipogenesis, and regulate lipid metabolism. AMP-activated protein kinase (AMPK) is regarded as important as it senses the cellular energy status and plays a critical role in the energy balance of the body through a concomitant inhibition of fatty acid synthesis and an activation of fatty acid oxidation [2]. Metabolic changes induced by AMPK involve both acute effects on the phosphorylation of key enzymes and chronic effects on the expression of genes involved in metabolic regulation [3]. Thus, AMPK has been recognized as a promising target for the management of obesity and hyperlipidemia.

Dietary acetic acid is metabolized to acetyl-CoA with the production of AMP [4], which, in vitro, results in the elevation of the AMP/ATP ratio and subsequent phosphorylation of AMPK [5]. Based on these findings, previous studies found that dietary acetic acid suppressed body fat accumulation in animals by regulating genes for energy consumption and fatty acid oxidation enzymes in liver [6]. However, the effects of dietary acetic acid on AMPK activation in adipose tissue remains relatively unexplored, although AMPK is ubiquitously expressed and plays an important role in various physiological and pathological processes in the liver and adipose tissue [7]. Furthermore, little information is available on the coordinated control of lipid metabolism through the phosphorylation of each AMPK protein and its downstream effectors in the liver and adipose tissue.

Finally, as many different kinds of vinegars are being introduced into the market, it is necessary to compare the relative bioactivities of newer vinegars. Pomegranate (Punicagranatum L.), a fruit native to the Middle East, and its juice and extracts are being widely promoted to consumers as a nutraceutical source. Therefore, this study was performed to compare the effects of new vinegar containing pomegranate extract (PV) with those of acetic acid on adiposity in high-fat diet-induced obese (DIO) rats. To provide mechanistic explanation, we also investigated the role of AMPK protein and its downstream effectors with a focus on the coordinated control of lipid metabolism between the liver and adipose tissue.

Results and discussion

In this study, the effects of PV on adiposity were compared with those of acetic acids in DIO rats, which have characteristics of excess body fat, dyslipidemia, and fatty liver.

Comparison of PV and acetic acid for attenuating adiposity in DIO rats

Changes in body weight, calorie intake, fat weight, and lipid profile in plasma and liver after a 16-week supplementation with PV or acetic acid are shown in Table 1. Although daily calorie intake was not different among the groups, both AH and VL supplementation significantly suppressed body weight increases induced by a high-fat diet (p = 0.048). Also AH or VL groups were also shown to decrease WAT. However, the dose-dependency was not clear in PV, resulting that changes in body weight and WAT were notably decreased in the VL group. Plasma triglyceride (TG) level was significantly lowered by acetic acid or PV supplementation compared with the HF control (p = 0.001), whereas plasma leptin level was tended to be decreased in the VL group only. Hepatic TG level was significantly lowered in the VL group versus the HF control (p = 0.005). These findings are consistent with data on body weight gain and adiposity.
Table 1

Effects of acetic acid or pomegranate vinegar supplementation on the body weight gain, calorie intake, fat weight, and lipid profile in plasma and liver in Sprague Dawley rats fed a high fat diet for 16 weeks

 

HF

AL

AH

VL

VH

Body weight gain (g/16 weeks)

268.6 ± 10.6a

247.2 ± 10.3ab

230.5 ± 5.1b

235.3 ± 12.8b

259.6 ± 12.3ab

Calorie intake (kcal/day)

107.8 ± 2.2

104.1 ± 3.1

107.4 ± 1.5

104.1 ± 3.1

106.2 ± 1.8

WAT mass (g/100 g BW)

     

Epididymal WAT

3.4 ± 0.1a

3.4 ± 0.0ab

3.3 ± 0.0ab

3.0 ± 0.1b

3.2 ± 0.1ab

Perirenal WAT

4.8 ± 0.2a

4.5 ± 0.1ab

4.3 ± 0.1b

4.3 ± 0.1b

4.4 ± 0.1ab

Plasma TG (mg/dL)

186.6 ± 8.9a

155.5 ± 10.8b

152.7 ± 8.1b

154.6 ± 10.4b

164.6 ± 10.1b

Plasma leptin (ng/mL)

10.2 ± 0.5

10.20 ± 0.9

9.9 ± 0.4

8.5 ± 0.4

9.84 ± 0.6

Hepatic TG (mg/g liver)

36.7 ± 4.5a

30.8 ± 3.0ab

30.0 ± 4.7ab

23.8 ± 1.9b

28.4 ± 3.1ab

Mean ± SEM (n = 10 per group). abMeans not sharing common letters are significantly different between groups at p < 0.05 by Duncan’s multiple range tests. BW, body weight; WAT, white adipose tissue; TG, triglycerides; HF, high fat diet; AL, high fat with HF, high fat diet; AL, HF with low-dose acetic acid; AH, HF with high-dose acetic acid; VL, HF with low-dose PV; VH, HF with high-dose PV.

It is worth to note that the effects of PV on fat utilization in the liver and decrease in body weight and plasma triglycerides were more potent at the low-dose than the high-dose, but the effects of low-dose PV showed slightly more or equal potency than high-dose acetic acid. It might be attributed to the chemical composition of PV. However, a limitation of this study is that it was not designed to aim at tracing the causative components in PV due to the highly diverse phytochemicals found in PV. Further complicating matters, phytochemicals are transformed in the body into various metabolites after ingestion [8]. Future studies are needed to identify the principal bioactive components in PV, such as testing the activity of each fraction in a suitable cell culture model or high-throughput assay system [9]. In the meantime, ellagic acid that was recognized as having a potential role in contributing to altered gene expression by PV treatment in human hepatocyte in a less-specific approach [10] can be used as a marker compound for the purpose of standardizing PV.

Effects of PV on the activation of AMPK and its downstream effectors in adipose tissue

Lipolysis in WAT is completed in a step-wise fashion initiated by adipose TG lipase and then hormone sensitive lipase (HSL) and monoacylglycerol lipase [11]. Existing literature indicates that high-fat diet feeding increased adipose TG lipase content in mouse, whereas activated HSL content was severely reduced [12], indicating that the hydrolysis of diacylglycerol by HSL is the rate-limiting step of WAT lipolysis [13]. It was also found that high-fat diet inhibited AMPK activation as well as PPARγ coactivator-1α expression, citrate synthase activity, and palmitate oxidation in WAT [12]. However, PV supplementation prevented high-fat diet induced changes in WAT as witnessed by up-regulation of HSL expression, down-regulation of SREBP-1c and PPARγ expression, and induction of AMPK activation in this study. Adipogenesis involves a highly regulated and coordinated cascade of transcription factors, such as members of the PPARs, the C/EBPs, and SREBP family, which together lead to the establishment of the differentiated state [14]. SREBP-1c, the most abundant form of SREBPs in adipose tissue and liver, controls the genes involved in lipogenesis. PPARγ also remarkably distributes in WAT and plays a crucial role in maintaining adipose expansion and adiposity [15]. AMPK signaling pathways have shown an inverse correlation with SREBP-1c as well as PPARγ in WAT [16]. Figure 1A shows the activaion of AMPK in WAT, indicating the phospho-AMPK levels in WAT were increased in the acetic acid and PV groups compared with the HF control. Expression of PPARγ mRNA was significantly decreased in VL group versus HF control (Figure 1B). In parallel with this, the expression of SREBP-1c mRNA was significantly decreased in the AL, VL, and VH groups compared to the HF control (Figure 1C). In contrast, the expression of HSL mRNA was significantly higher in the PV groups versus the HF control (Figure 1D). In particular, the VL group showed much greater increase in comparison to the HF control. The biological role of uncoupling protein2 (UCP2) is less clear, although some evidence suggests a role for this protein in energy balance and thermogenesis [17]. The results of the present study indicate that UCP2 mRNA was also significantly increased in the VL group only in comparison to the HF control (Figure 1E) in adipose tissue. However, CPT-1a, the rate-limiting enzyme of mitochondrial fatty acid oxidation, mRNA level was not changed with acetic acid or PV supplementation (Figure 1 F). Collectively, it appeared that PV promoted lipolysis as well as created milieu for preventing re-esterification of lipolytic products in WAT. Therefore, the net result was to favor lipid removal from WAT. The classical mechanism to explain these characteristics is highlighted by fact that dysregulation of lipolysis may lead to metabolic abnormalities [18, 19].
Figure 1

Effects of pomegranate vinegar or acetic acid supplementation on the p-AMPK protein (A), PPARγ (B), SREBP-1c (C), HSL (D), UCP2 (E), CPT-1a (F) mRNA levels in adipose tissue of SD rats fed a HF diet for 16 weeks ( n= 10 per group). Representative western blots of adipose tissue lysate with antibodies against AMPK, p-AMPK and β-actin as loading control. Total protein (50 ug) from the adipose tissue was electrophoresed on to SDS-phage gel and transferred to PVDF membranes. The effects of dietary PV or acetic acid supplementation on key lipolysis enzyme mRNA levels were examined by real-time PCR. The results represent each mRNA/ β-actin expression ratio. Data are shown as the mean ± SEM. abcMeans not sharing common letters are significantly different between groups at p < 0.05.

Effects of PV on the activation of AMPK and its downstream effectors in the liver

Abnormalities of peripheral lipid storage in obesity may result in overflow of lipid to the liver, leading to hepatic fat accumulation [20]. This study revealed that PV promoted fatty acid oxidation and inhibited lipogenesis in the liver as evidenced by the phosphorylation of AMPK as well as up-regulation of PPARα and CPT-1a expression and down-regulation of SREBP-1c expression. AMPK has been identified as a key regulator of lipid homeostasis in the liver [21], yielding a net effect of increasing fatty acid oxidation and diminishing glycerolipid synthesis. Figure 2A shows the increase in the AMPK phosphorylation after acetic acid or PV supplementation as compared to the HF control. In addition, the expression of both lipogenesis- and fatty acid oxidation-related genes was determined in the liver. The expressions of PPARα and CPT-1a mRNA were stimulated in the AH, VL, and VH group compared to the HF control (Figure 2B and C, respectively), while the expression of SREBP-1c mRNA, a transcription factor controlling lipogenesis, significantly declined only in the AH group, but tended to decrease in the AL, VL, and VH groups compared to the HF control (Figure 2D). The expressions of acyl-CoA oxidase (ACO) and UCP2 mRNA were not changed (Figure 2E and F, respectively). The effect of PV is not significantly different compared with that of acetic acid. These results are in agreement with the study by Kondo et al.[6] who found up-regulation of PPARα, ACO, CPT-1 and UCP2 genes after the addition of acetic acid to HepG2 cells. However, the up-regulation of PPARα and CPT-1a mRNA expressions and the phosphorylation of AMPK were more pronounced with PV than with acetic acid.
Figure 2

Effects of pomegranate vinegar or acetic acid supplementation on the p-AMPK protein (A), PPARα (B), CPT-1a (C), SREBP-1c (D), ACO (E), UCP2 (F) mRNA levels in the liver of SD rats fed a HF diet for 16 weeks ( n= 10 per group). Representative western blots of adipose tissue lysate with antibodies against AMPK, p-AMPK and β-actin as loading control. Total protein (40 ug) from the liver was electrophoresed on to SDS-phage gel and transferred to PVDF membranes. The effects of dietary PV or acetic acid supplementation on hepatic key lipolysis enzyme mRNA levels were examined by real-time PCR. Data are shown as the mean ± SEM. abcMeans not sharing common letters are significantly different between groups at p < 0.05.

Coordinated control of energy metabolism by PV in adipose tissue and liver

Vinegar intake reduced body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects and attenuated lipid profile in diabetic rats [22, 23]. In addition, dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet [24]. In this study, PV showed higher potency than acetic acid in promoting lipolysis via increase of HSL mRNA in adipose tissue as well as fatty acid oxidation via increase of CPT-1a mRNA in liver. Taken together, our data support the potential health benefits of PV in coordinated control of energy metabolism through AMPK activation between liver and adipose tissue better than acetic acid. Especially, these findings, at molecular level, firmly proved that the low-dose PV exerted higher potency than the high-dose PV in adipose tissue. Adipose tissue stores excess energy under positive energy balance conditions, whereas it provides energy for other organs by releasing fatty acids under negative energy balance conditions. Excess fatty acids release from the adipose tissue may cause fatty acid overflux into the liver with the development of liver steatosis. The coordinated control of lipid metabolism between these two organs might be important to maximize the overall effectiveness of lipid disposal. It created an environment where the net metabolic effect is to favor lipid removal, which was associated with the interaction between p-AMPK-induced up-regulation of HSL mRNA and down-regulation of PPARγ and SREBP-1c mRNA in adipose tissue and AMPK-induced up-regulation of PPARα and CPT-1a mRNA and down-regulation of SREBP-1c mRNA in liver.

Conclusions

Consequently, PV prevented hepatic lipid deposition by overflow of lipid to the liver resulting from abnormalities of peripheral lipid storage in HF status. It suggests that AMPK activation of PV might act as an energy sensor between liver and adipose tissue to improve metabolic health. Further study is warranted to investigate whether PV intake may help to protect dyslipidemia and to maintain a healthy body weight in overweight subjects.

Methods

Chemicals

Acetic acid and ellagic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies (AMPK and phospho-AMPK) were purchased from Cell Signaling Technology (Denver, MA, USA). All solvents were purchased from Merck (Darmstadt, Germany).

Materials

The PV was obtained from Daesang Corp. (Seoul, Korea). Briefly, pomegranate extract was added after the alcohol fermentation and then acetic acid fermentation was continued. The PV was standardized with acetic acid and ellagic acid by using high-performance liquid chromatography (HPLC, Agilent Technologies 1200, Santa Clara, CA, USA, Table 2). Acetic acid was analyzed using Aminex HPX-87H cation-exchange column (300 × 7.8 mm; Bio-Rad, Hercules, CA, USA) and a UV detector (210 nm); ellagic acid was analyzed using C18 Halo column (100 × 2.1 mm; HiChrom, Berkshire, UK) and a UV detector (360 nm) as described in our previous study [10].
Table 2

Composition of pomegranate vinegar

(g/100 mL)

Pomegranate vinegar

Oxalic acid

0.22

Citric acid

1.02

Malic acid

0.01

Succinic acid

0.06

Lactic acid

0.04

Total organic acid

0.84

Acetic acid

2.16

Total acid

4.6

Ellagic acid

0.001

Brix

29.3

pH

2.8

Animal and diets

Ten-week-old male Sprague–Dawley rats were purchased from Jung-Ang Lab Animal Inc. (Seoul, Korea). The rats were housed individually with a 12 h light/dark cycle at a temperature of 23 ± 1°C and a humidity of 45 ± 5% with access to water and chow diet(Samyang Co, Incheon, Korea) for a week prior to the experiment. For the experiment, rats were randomly divided into five groups (n = 10 for each) and fed the designated experimental diet (Table 3) for 16 weeks: high-fat diet (HF; modified AIN-93G diet containing 41.2% energy from fat), low-dose acetic acid (AL; HF with 6.5% (w/w) acetic acid; equivalent to 1.6% acetic acid per rat), high-dose acetic acid (AH; HF with 13% (w/w) acetic acid; equivalent to 3.2% acetic acid per rat), low-dose PV (VL; HF with 6.5% (w/w) PV; equivalent to 1.62% PV per rat) and high-dose PV group (VH; HF with 13% (w/w) PV; equivalent to 3.2% acetic acid per rat).
Table 3

Composition of experimental diets

(g/kg)

HF

AL

AH

VL

VH

Cornstarch

290.6

290.6

290.6

290.6

290.6

Dextrinized cornstarch

90.0

90.0

90.0

90.0

90.0

Sucrose

70.0

70.0

70.0

70.0

70.0

Casein (>85% protein)

100.0

100.0

100.0

100.0

100.0

Soybean oil

100.0

100.0

100.0

100.0

100.0

Lard

230.0

230.0

230.0

230.0

230.0

Fiber

60.0

60.0

60.0

60.0

60.0

Mineral mixa

41.0

41.0

41.0

41.0

41.0

Vitamin mixb

12.0

12.0

12.0

12.0

12.0

L-Cystine

3.5

3.5

3.5

3.5

3.5

Choline bitartrate

2.9

2.9

2.9

2.9

2.9

Tert-butylhydroquinone

0.0

0.0

0.0

0.0

0.0

Distilled water

150.0

75.0

0.0

75.0

0.0

Pomegranate vinegar (PV)

0.0

0.0

0.0

75.0

150.0

Acetic acid

0.0

75.0

150.0

0.0

0.0

Total amount

1,150.0

1,150.0

1,150.0

1,150.0

1,150.0

Total calories (kcal)

4372.7

4372.7

4372.7

4372.7

4372.7

Carbohydrates (% as kcal)

39.7

39.7

39.7

39.7

39.7

Protein (% as kcal)

19.1

19.1

19.1

19.1

19.1

Fat (% as kcal)

41.2

41.2

41.2

41.2

41.2

HF, high fat diet; AL, HF with low-dose acetic acid; AH, HF with high-dose acetic acid; VL, HF with low-dose PV; VH, HF with high-dose PV.

aMineral mix (AIN-93G-MIX, g/kg mixture).

bVitamin mix (AIN-93G-MIX, g/kg mixture).

The AL and AH group contained the same amount of acetic acid as the VL and VH group, respectively. The doses were determined on the basis of the previously published studies [6, 25]. Body weights and food intakes were recorded weekly. Calorie intakes toward daily intakes were also converted. After the 16-week study period, liver and white adipose tissue (WAT: epididymal and perirenal fat pads) were removed in an overnight fasting state and stored at -80°C before use. Blood was also collected and quickly centrifuged at 4°C for 10 min. The serum fraction was collected and stored at -80°C for later analysis. The experimental protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at Ewha Womans University (Reference # 2010-14-1).

Biochemical assays

Plasma and hepatic TG were measured enzymatically using commercially available assay kits (Asan Pharm, Hwasung, Korea). For determination of hepatic TG content, liver tissue was homogenized and then total lipid was extracted by Bligh’s method [26]. Plasma leptin was measured using a radioimmunoassay kit (Invitrogen, Carlsbad, CA, USA).

Quantitative TaqMan reverse transcription polymerase chain reaction analysis

Total RNA was extracted from liver and adipose tissue using TRIZOL (Invitrogen Co., Carlsbad, CA, USA). RNA concentration and quality were determined by a BioSpec-nano (Shimadzu Corp., Kyoto, Japan). cDNA was constructed using the High Capacity RNA-to-cDNA kit (Applied Biosystems, Foster City, CA, USA). Quantitative RT-PCR was performed using the TaqMan method in a Step-One-Plus RT-PCR System (Applied Biosystems). The primer sets for target genes were PPARα (Rn00566193_m1), SREBP-1c (Rn01446560_m1), PPARγ (Rn00440940_m1), ACO (Rn00569216_m1), CPT-1a (Rn00580702_m1), HSL (Rn00563444_m1), UCP2 (Rn01754856_m1) and β-actin (Rn00667869_m1). The relative amounts of these mRNAs were normalized to the amount of β-actin and the relative amounts of all RNAs were calculated using the comparative CT Method [27].

Western blot analysis

Liver and adipose tissue protein was extracted with lysis buffer (Intron Biotech, Seoul, Korea) and quantified using the Bradford method. Equal amount of proteins were electrophoresed using 0.1% SDS-polyacrylamide gel, transferred to polyvinylidenedifluoride membranes (Bio-Rad, CA, USA), incubated with 5% skimmed milk in Tris-buffered saline, and treated with rabbit anti-p-AMPK or rabbit anti-AMPK and mouse anti-β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The immunoreactive antigen was then recognized by using a horseradish peroxidase-labeled anti-rabbit or anti-mouse IgG (Santa Cruz Biotechnology). Immunoreactive protein bands were visualized by ChemiDoc XRS System (Bio-Rad, CA, USA).

Statistical analysis

Results were presented as mean ± standard error of mean (SEM). Statistical analyses were performed by the Statistical Analysis Systems package, version 9.2 (SAS Institute, Cary, NY, USA). The differences between treated groups were analyzed by one-way analysis of variance (ANOVA) with post hoc Duncan’s multiple range tests. Results were considered statistically significant at p < 0.05.

Notes

Abbreviations

ACO: 

Acyl-CoA oxidase

AMPK: 

AMP-activated protein kinase

CPT-1: 

Carnitinepalmitoyltransferase-1

HF: 

High-fat diet

HSL: 

Hormone sensitive lipase

PPAR: 

Peroxisome proliferator-activated receptor

PV: 

Pomegranate vinegar

SREBP-1c: 

Sterol regulatory element binding protein-1c

TG: 

Triglyceride

UCP-2: 

Uncoupling protein-2

WAT: 

White adipose tissue.

Declarations

Acknowledgements

We thank the company Daesang Corporation (Seoul, Korea) for its gift of pomegranate vinegar. This project was supported by Ministry of Knowledge and Economy (National Platform Technology Project B10033818).

Authors’ Affiliations

(1)
Department of Nutritional Science and Food Management, Ewha Womans University

References

  1. Kopelman PG: Obesity as a medical problem. Nature. 2000, 404 (6778): 635-643.PubMedGoogle Scholar
  2. Kemp B, Stapleton D, Campbell D, Chen ZP, Murthy S, Walter M, Gupta A, Adams J, Katsis F, Van Denderen B: AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans. 2003, 31: 162-168.View ArticlePubMedGoogle Scholar
  3. Kola B, Grossman AB, Korbonits M: The role of AMP-activated protein kinase in obesity. Front Horm Res. 2008, 36: 198-211.View ArticlePubMedGoogle Scholar
  4. Mortensen PB, Clausen MR: Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996, 216: 132-View ArticlePubMedGoogle Scholar
  5. Hardie DG, Scott JW, Pan DA, Hudson ER: Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003, 546 (1): 113-120. 10.1016/S0014-5793(03)00560-XView ArticlePubMedGoogle Scholar
  6. Kondo T, Kishi M, Fushimi T, Kaga T: Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. J Agric Food Chem. 2009, 57 (13): 5982-5986. 10.1021/jf900470cView ArticlePubMedGoogle Scholar
  7. Lim CT, Kola B, Korbonits M: AMPK as a mediator of hormonal signalling. J Mol Endocrinol. 2010, 44 (2): 87-97. 10.1677/JME-09-0063View ArticlePubMedGoogle Scholar
  8. Manach C, Hubert J, Llorach R, Scalbert A: The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol Nutr Food Res. 2009, 53 (10): 1303-1315. 10.1002/mnfr.200800516View ArticlePubMedGoogle Scholar
  9. Kim JY, Kwon O: Culinary plants and their potential impact on metabolic overload. Ann N Y Acad Sci. 2011, 1229 (1): 133-139. 10.1111/j.1749-6632.2011.06090.xView ArticlePubMedGoogle Scholar
  10. Kim JY, Ok E, Kim YJ, Choi K-S, Kwon O: Oxidation of fatty acid may be enhanced by a combination of pomegranate fruit phytochemicals and acetic acid in HepG2 cells. Nutr Res Pract. 2013, 7 (3): 153-159. 10.4162/nrp.2013.7.3.153PubMed CentralView ArticlePubMedGoogle Scholar
  11. Langin D: Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res. 2006, 53 (6): 482-491. 10.1016/j.phrs.2006.03.009View ArticlePubMedGoogle Scholar
  12. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB: Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol. 2010, 298 (4): C961-C971. 10.1152/ajpcell.00547.2009View ArticlePubMedGoogle Scholar
  13. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R: Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem. 2006, 281 (52): 40236-40241. 10.1074/jbc.M608048200View ArticlePubMedGoogle Scholar
  14. Brown MS, Goldstein JL: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997, 89 (3): 331-340. 10.1016/S0092-8674(00)80213-5View ArticlePubMedGoogle Scholar
  15. Anghel SI, Wahli W: Fat poetry: a kingdom for PPAR gamma. Cell Res. 2007, 17 (6): 486-511. 10.1038/cr.2007.48View ArticlePubMedGoogle Scholar
  16. Kersten S: Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2001, 2 (4): 282-286. 10.1093/embo-reports/kve071PubMed CentralView ArticlePubMedGoogle Scholar
  17. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet. 1997, 15 (3): 269-272.View ArticlePubMedGoogle Scholar
  18. Arner P: Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005, 19 (4): 471-482. 10.1016/j.beem.2005.07.004View ArticlePubMedGoogle Scholar
  19. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS: Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol. 2007, 293 (1): G1-G4. 10.1152/ajpgi.00554.2006PubMed CentralView ArticlePubMedGoogle Scholar
  20. Drake AJ, Raubenheimer PJ, Kerrigan D, McInnes KJ, Seckl JR, Walker BR: Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet. Endocrinology. 2010, 151 (4): 1581-1587. 10.1210/en.2009-1088View ArticlePubMedGoogle Scholar
  21. Hardie DG: Sensing of energy and nutrients by AMP-activated protein kinase. Am J Clin Nutr. 2011, 93 (4): 891S- 10.3945/ajcn.110.001925View ArticlePubMedGoogle Scholar
  22. Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T: Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Biosci Biotechnol Biochem. 2009, 73 (8): 1837-1843. 10.1271/bbb.90231View ArticlePubMedGoogle Scholar
  23. Shishehbor F, Mansoori A, Sarkaki AR, Jalali MT, Latifi SM: Apple cider vinegar attenuates lipid profile in normal and diabetic rats. Pak J Biol Sci. 2008, 11 (23): 2634-2638. 10.3923/pjbs.2008.2634.2638View ArticlePubMedGoogle Scholar
  24. Fushimi T, Suruga K, Oshima Y, Fukiharu M, Tsukamoto Y, Goda T: Dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed acholesterol-rich diet. Br J Nutr. 2006, 95 (5): 916-924. 10.1079/BJN20061740View ArticlePubMedGoogle Scholar
  25. Yamashita H, Fujisawa K, Ito E, Idei S, Kawaguchi N, Kimoto M, Hiemori M, Tsuji H: Improvement of obesity and glucose tolerance by acetate in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci Biotechnol Biochem. 2007, 71 (5): 1236-1243. 10.1271/bbb.60668View ArticlePubMedGoogle Scholar
  26. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959, 37 (8): 911-917. 10.1139/o59-099View ArticlePubMedGoogle Scholar
  27. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008, 3 (6): 1101-1108. 10.1038/nprot.2008.73View ArticlePubMedGoogle Scholar

Copyright

© Ok et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.